Nipent

Active Ingredient(s): Pentostatin
FDA Approved: * October 11, 1991
Pharm Company: * SUPERGEN
Category: Cancer

Pentostatin (or deoxycoformycin, trade name Nipent, manufactured by SuperGen) is an anticancer chemotherapeutic drug.[1] Mechanism It is classified as a purine analog, which is a type of antimetabolite. It mimics the nucleoside adenosine and thus inhibits the enzyme adenosine deaminase, interfering with the cell's ability to process DNA.[2] Cancer cells generally divide more often than healthy cells; DNA is highly involved in cell division (mitosis) and drug... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Nipent 2 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution

NDC: 0409-0801

Labeler:

Hospira, Inc.